Coherus Biosciences | CHRS - Azione





Azione Cambiamento Data
AbbVie USD 4.95B 13M 2025-12
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Akebia Therapeutics USD 15.61M 3.03M 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amarin USD 184.7M 13.46M 2025-09
Amgen USD 6.22B 121M 2025-12
Baxter International USD 2.23B 228M 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
Fujifilm JPY 600.12B 1.55B 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
Merck USD 6.44B 157M 2025-09
Myriad Genetics USD 30.6M 1000K 2025-12
Pacira USD 152.86M 4.82M 2025-12
Perrigo USD 1.15B 78M 2025-12
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12
Zoetis USD 2.43B 35M 2025-12